Loading organizations...
Artera is a precision medicine company that develops artificial intelligence-driven predictive and prognostic tests for personalized cancer care, based in San Francisco, California. The organization utilizes multimodal artificial intelligence to analyze digital pathology images and clinical data, assisting healthcare providers in tailoring specific therapies for oncology patients. Operating primarily within the urology and oncology sectors, the enterprise has secured $90 million in venture capital funding to scale its proprietary diagnostic technologies. The company is backed by a syndicate of notable institutional and corporate investors, including Coatue, Johnson & Johnson Innovation, and Breyer Capital. Following its public launch, the firm achieved a significant milestone when its flagship prostate cancer test was incorporated into the National Comprehensive Cancer Network clinical practice guidelines. Artera was founded in 2021 by Andre Esteva, Felix Feng, Todd Morgan, and Tim Triche.
Artera has raised $155.0M across 3 funding rounds.
Artera has raised $155.0M in total across 3 funding rounds.
Artera is a technology company specializing in AI-powered virtual agents and digital communication solutions primarily for the healthcare sector. Its flagship product enhances the entire patient experience by automating and streamlining patient communications across voice, text, and web channels. Serving over 1,000 healthcare provider organizations and engaging 100 million patients annually, Artera addresses administrative and clinical workflow challenges such as scheduling, intake, billing, and follow-up, improving efficiency and patient satisfaction. The company has demonstrated strong growth momentum, recently securing $65 million in growth investment and reaching $100 million in annual recurring revenue (CARR)[1][2][4][8].
Founded in 2015, Artera emerged from a vision to transform patient experience through technology by delivering concierge-level communication services. The company has built on a decade of healthcare expertise, leveraging AI to solve real-world problems in patient engagement. Early traction came from deploying its Harmony platform and AI Agents that automate complex workflows, enabling healthcare organizations to reduce administrative burdens and improve patient access. This foundation has allowed Artera to evolve rapidly, embracing emerging standards like Model Context Protocol (MCP) and pioneering fully autonomous AI Agents that manage the full patient care journey[1][2][4][9].
Artera rides the growing trend of AI and automation in healthcare, addressing the critical need for efficient patient communication amid increasing administrative complexity and demand for personalized care. The timing is favorable due to healthcare’s vast market size, regulatory pressures to improve patient engagement, and the accelerating adoption of AI technologies. By pioneering agentic AI that blends human and machine intelligence, Artera influences the broader ecosystem by setting new standards for patient communication automation and enabling healthcare providers to deliver more responsive, scalable, and cost-effective services[1][2][8].
Looking ahead, Artera is poised to expand its leadership in AI-driven patient communications by further refining autonomous AI Agents and broadening its integration capabilities. Trends such as increased telehealth adoption, personalized patient engagement, and regulatory emphasis on patient experience will shape its journey. Artera’s influence is likely to grow as healthcare organizations increasingly rely on AI to reduce costs and improve outcomes, positioning the company as a key enabler of the digital transformation in healthcare communication[1][2][8][9]. Its mission to provide every patient with a concierge-level experience through AI-human collaboration remains central to its future trajectory.
Artera has raised $155.0M across 3 funding rounds. Most recently, it raised $20.0M Series U in January 2024.
Artera has raised $155.0M in total across 3 funding rounds.
Artera's investors include Michael Driscoll, Freestyle Capital, Insight Partners, Jackson Square Ventures, M34 Capital, Mayfield, Nepenthe Capital, Redline Capital, Walden International, Marc Benioff, AirAngels, AIX Ventures.
